Thomson Medical (SGX:A50) narrowed its attributable loss to owners to SG$10.2 million in the fiscal first half ended Dec. 31, 2025, from SG$12.9 million a year earlier, according to a Wednesday filing with the Singapore Exchange.
Loss per share narrowed to SG$0.00039 from SG$0.00049 a year ago.
Revenue jumped 7% year over year to SG$213.1 million from SG$199.1 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.